Citius Pharmaceuticals, Inc. Interest Expense, Related Party
Citius Pharmaceuticals, Inc. (CTXR) reported Interest Expense, Related Party of $9.61 thousand for the 12-month period ending 2021-09-30, per its 10-K filed 2022-12-22.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseRelatedParty · last filed 2022-12-22
- Citius Pharmaceuticals, Inc. interest expense, related party for the quarter ending 2021-09-30 was $1.00, a 99.97% decline year-over-year.
- Citius Pharmaceuticals, Inc. interest expense, related party for the quarter ending 2021-06-30 was $2.51K, a 35.81% decline year-over-year.
- Citius Pharmaceuticals, Inc. interest expense, related party for the quarter ending 2021-03-31 was $3.53K, a 0.00% change year-over-year.
- Citius Pharmaceuticals, Inc. interest expense, related party for the quarter ending 2020-12-31 was $3.56K, a 10.72% decline year-over-year.
- Citius Pharmaceuticals, Inc. interest expense, related party for fiscal 2021 was $9.61K, a 35.67% decline from fiscal 2020.
- Citius Pharmaceuticals, Inc. interest expense, related party for fiscal 2020 was $14.93K, a 9.19% decline from fiscal 2019.
- Citius Pharmaceuticals, Inc. interest expense, related party for fiscal 2019 was $16.44K.
- Citius Pharmaceuticals, Inc. interest expense, related party for fiscal 2012 was $1.58K, a 124.86% increase from fiscal 2011.
| Period end | Interest Expense, Related Party 3 month | Interest Expense, Related Party 3 month as first filed | Interest Expense, Related Party 6 month | Interest Expense, Related Party 9 month | Interest Expense, Related Party 12 month |
|---|---|---|---|---|---|
| 2021-09-30 | $1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-22 | $2.51K derived: sum of 2 quarters · filed 2022-12-22 | $6.04K derived: sum of 3 quarters · filed 2022-12-22 | $9.61K 10-K · filed 2022-12-22 | |
| 2021-06-30 | $2.51K 10-Q · filed 2022-08-11 | $6.04K derived: sum of 2 quarters · filed 2022-08-11 | $9.61K 10-Q · filed 2022-08-11 | $12.66K derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | $3.53K 10-Q · filed 2022-05-12 | $3.98K 10-Q · filed 2021-05-13 | $7.10K 10-Q · filed 2022-05-12 | $10.15K derived: sum of 3 quarters · filed 2022-05-12 | $14.06K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $3.56K 10-Q · filed 2022-02-10 | $6.62K derived: sum of 2 quarters · filed 2022-02-10 | $10.52K derived: sum of 3 quarters · filed 2022-02-10 | $14.06K derived: sum of 4 quarters · filed 2022-02-10 | |
| 2020-09-30 | $3.05K derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-15 | $6.96K derived: sum of 2 quarters · filed 2021-12-15 | $10.49K derived: sum of 3 quarters · filed 2021-12-15 | $14.93K 10-K · filed 2021-12-15 | |
| 2020-06-30 | $3.91K 10-Q · filed 2021-08-12 | $7.44K derived: sum of 2 quarters · filed 2021-08-12 | $11.88K 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $3.53K 10-Q · filed 2021-05-13 | $7.97K 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | $3.99K 10-Q · filed 2021-02-11 | ||||
| 2019-09-30 | $16.44K 10-K · filed 2020-12-16 | ||||
| 2013-03-31 | $428.00 10-Q · filed 2013-05-13 | $865.00 10-Q · filed 2013-05-13 | |||
| 2012-12-31 | $437.00 10-Q · filed 2013-02-08 | ||||
| 2012-09-30 | $1.58K 10-K · filed 2013-01-15 | ||||
| 2012-03-31 | $369.00 10-Q · filed 2013-05-13 | $741.00 10-Q · filed 2013-05-13 | |||
| 2011-12-31 | $372.00 10-Q · filed 2013-02-08 | ||||
| 2011-09-30 | $704.00 10-K · filed 2013-01-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |